Nkarta, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Nkarta, Inc. (NKTX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 32.99 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-12
- Nkarta, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 32.99M shares, a 0.77% increase year-over-year.
- Nkarta, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 32.96M shares, a 0.70% increase year-over-year.
- Nkarta, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 32.90M shares, a 6.20% increase year-over-year.
- Nkarta, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 32.83M shares, a 1832.66% increase year-over-year.
- Nkarta, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 32.86M shares, a 95.50% increase from fiscal 2020.
- Nkarta, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 16.81M shares, a 1049.14% increase from fiscal 2019.
- Nkarta, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 1.46M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 32.99M shares 10-Q · filed 2022-05-12 | 32.97M shares derived: average of 2 quarters · filed 2022-05-12 | 32.95M shares derived: average of 3 quarters · filed 2022-05-12 | 32.92M shares derived: average of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | 32.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 32.93M shares derived: average of 2 quarters · filed 2022-03-17 | 32.90M shares derived: average of 3 quarters · filed 2022-03-17 | 32.86M shares 10-K · filed 2022-03-17 |
| 2021-09-30 | 32.90M shares 10-Q · filed 2021-11-10 | 32.87M shares derived: average of 2 quarters · filed 2021-11-10 | 32.82M shares 10-Q · filed 2021-11-10 | 32.80M shares derived: average of 4 quarters · filed 2022-05-12 |
| 2021-06-30 | 32.83M shares 10-Q · filed 2021-08-12 | 32.78M shares 10-Q · filed 2021-08-12 | 32.76M shares derived: average of 3 quarters · filed 2022-05-12 | 32.32M shares derived: average of 4 quarters · filed 2022-05-12 |
| 2021-03-31 | 32.74M shares 10-Q · filed 2022-05-12 | 32.73M shares derived: average of 2 quarters · filed 2022-05-12 | 32.15M shares derived: average of 3 quarters · filed 2022-05-12 | 24.54M shares derived: average of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | 32.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 31.85M shares derived: average of 2 quarters · filed 2022-03-17 | 21.80M shares derived: average of 3 quarters · filed 2022-03-17 | 16.81M shares 10-K · filed 2022-03-17 |
| 2020-09-30 | 30.98M shares 10-Q · filed 2021-11-10 | 16.34M shares derived: average of 2 quarters · filed 2021-11-10 | 11.50M shares 10-Q · filed 2021-11-10 | 8.97M shares derived: average of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | 1.70M shares 10-Q · filed 2021-08-12 | 1.65M shares 10-Q · filed 2021-08-12 | 1.63M shares derived: average of 3 quarters · filed 2021-08-12 | 1.61M shares derived: average of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | 1.61M shares 10-Q · filed 2021-05-13 | 1.60M shares derived: average of 2 quarters · filed 2021-05-13 | 1.57M shares derived: average of 3 quarters · filed 2021-05-13 | 1.54M shares derived: average of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | 1.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 1.56M shares derived: average of 2 quarters · filed 2021-03-25 | 1.51M shares derived: average of 3 quarters · filed 2021-03-25 | 1.46M shares 10-K · filed 2021-03-25 |
| 2019-09-30 | 1.53M shares 10-Q · filed 2020-11-12 | 1.48M shares derived: average of 2 quarters · filed 2020-11-12 | 1.42M shares 10-Q · filed 2020-11-12 | |
| 2019-06-30 | 1.43M shares 10-Q · filed 2020-08-20 | 1.37M shares 10-Q · filed 2020-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |